FDA Inspection
OrBion Pharmaceuticals Private LimitedOrBion Pharmaceuticals Private Limited – FDA Inspection, Oct 27, 2025
Record Details
This FDA Inspection record concerns OrBion Pharmaceuticals Private Limited, with an inspection on October 27, 2025, covering human drugs.
- Inspection Date
- October 27, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 7a98f743-d490-4a8f-a7fa-8120ad8e373a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1289382
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
FDA Citations
2- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.194(a)Complete test data included in records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OrBion Pharmaceuticals Private Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 10, 2024 | Not classified | Office of Inspections and Investigations | |
| September 8, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 15, 2016 | Not classified | Office of Inspections and Investigations | |
| June 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for OrBion Pharmaceuticals Private Limited
- FDA Inspection 1240651 - 2024-05-10
- FDA Inspection 1217144 - 2023-09-08
- FDA Inspection 1091278 - 2019-05-31
- FDA Inspection 1001296 - 2016-12-15
- FDA Inspection 934390 - 2015-06-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.